Biosynthesis and glycosylation of the carcinoembryonic antigen

Biochem J. 1988 Nov 1;255(3):943-8. doi: 10.1042/bj2550943.

Abstract

Human gastric adenocarcinoma MKN-45 cells were found to synthesize actively carcinoembryonic antigen (CEA). The biosynthesis and carbohydrate processing of CEA were studied in these cells by means of metabolic labelling followed by immunoadsorption with a specific polyclonal-antibody preparation and gel electrophoresis. Pulse-chase studies with [14C]leucine and [3H]mannose (shortest pulse 3 min) showed that N-linked oligosaccharide side chains are added to the protein co-translationally, producing a high-mannose immature CEA; the average molecular mass of this form is 145 kDa. The protein is later translocated to the Golgi apparatus and here undergoes additional processing; these modifications are visible in our system as a broadening of the CEA band and require about 4 h. The upper limit of mature CEA band reaches 200 kDa, but radioactivity is maximally incorporated at 168 kDa. The extent of co-translational glycosylation was measured by treating the cells with tunicamycin; in the presence of this inhibitor, a 74 kDa aglyco-CEA was produced and was still recognized by the antibody. Monensin, an ionophore which interferes with glycoprotein maturation and terminal sugar addition, blocked broadening of the CEA band, producing a sharp 141 kDa peak. In conclusion, CEA appears to be synthesized as a 145 kDa high-mannose immature form, the protein core accounting for about half of its molecular mass. Full maturation results in a broad band at 168 kDa.

MeSH terms

  • Antibodies / analysis
  • Carcinoembryonic Antigen / analysis*
  • Cell Line
  • Electrophoresis, Polyacrylamide Gel
  • Glycosylation
  • Humans
  • Immunosorbent Techniques
  • Monensin / pharmacology
  • Tumor Cells, Cultured / drug effects
  • Tumor Cells, Cultured / immunology
  • Tunicamycin / pharmacology

Substances

  • Antibodies
  • Carcinoembryonic Antigen
  • Tunicamycin
  • Monensin